Medlab Clinical shares jump as TGA frees up cannabis drug access

There are 30,000 new Australian patients diagnosed with advanced cancer pain every year, who could potentially benefit from medicinal cannabis. Medlab outlined to its investors today that for patients classified by the TGA as Category A, those approaching death, medical practitioners can prescribe a ...

read more here
Delivered by @can_nab_is